- Home
- UONEK vs FGEN Comparison
UONEK vs FGEN Comparison
Compare UONEK & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONEK
- FGEN
- Stock Information
- Founded
- UONEK 1980
- FGEN 1993
- Country
- UONEK United States
- FGEN United States
- Employees
- UONEK N/A
- FGEN N/A
- Industry
- UONEK Broadcasting
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- UONEK Consumer Discretionary
- FGEN Health Care
- Exchange
- UONEK Nasdaq
- FGEN Nasdaq
- Market Cap
- UONEK 28.1M
- FGEN 33.5M
- IPO Year
- UONEK N/A
- FGEN 2014
- Fundamental
- Price
- UONEK $0.66
- FGEN $8.71
- Analyst Decision
- UONEK
- FGEN Strong Buy
- Analyst Count
- UONEK 0
- FGEN 2
- Target Price
- UONEK N/A
- FGEN $146.50
- AVG Volume (30 Days)
- UONEK 135.5K
- FGEN 30.1K
- Earning Date
- UONEK 08-19-2025
- FGEN 08-11-2025
- Dividend Yield
- UONEK N/A
- FGEN N/A
- EPS Growth
- UONEK N/A
- FGEN N/A
- EPS
- UONEK N/A
- FGEN N/A
- Revenue
- UONEK $437,499,000.00
- FGEN $6,996,000.00
- Revenue This Year
- UONEK N/A
- FGEN N/A
- Revenue Next Year
- UONEK N/A
- FGEN N/A
- P/E Ratio
- UONEK N/A
- FGEN N/A
- Revenue Growth
- UONEK N/A
- FGEN N/A
- 52 Week Low
- UONEK $0.44
- FGEN $4.50
- 52 Week High
- UONEK $1.44
- FGEN $21.94
- Technical
- Relative Strength Index (RSI)
- UONEK 50.64
- FGEN 69.92
- Support Level
- UONEK $0.64
- FGEN $6.72
- Resistance Level
- UONEK $0.69
- FGEN $7.56
- Average True Range (ATR)
- UONEK 0.05
- FGEN 0.45
- MACD
- UONEK 0.00
- FGEN 0.09
- Stochastic Oscillator
- UONEK 65.38
- FGEN 93.87
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.